The groundbreaking treatment of this peptide represents a major advance in the care of the condition. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide335559.blogadvize.com/50608838/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment